Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial.

Autor: Tittanegro T; Institute of Liver and Digestive Health, University College London, United Kingdom., China L; Institute of Liver and Digestive Health, University College London, United Kingdom., Forrest E; Glasgow Royal Infirmary, Glasgow, United Kingdom., Kallis Y; Barts and the London School of Medicine and Dentistry Queen Mary University of London, United Kingdom., Ryder SD; National Institute for Health Research Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust, and the University of Nottingham, Queens Medical Centre, Nottingham, United Kingdom., Wright G; Mid and South Essex NHS Foundation Trust, Basildon & Thurrock University Hospitals NHS Foundation Trust, The Royal Free Hospital, University College London, Kings College London, United Kingdom., Freemantle N; Comprehensive Clinical Trials Unit, University College London, United Kingdom., O'Brien A; Institute of Liver and Digestive Health, University College London, United Kingdom.; Comprehensive Clinical Trials Unit, University College London, United Kingdom.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2022 Nov 14; Vol. 55, pp. 101716. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2023).